VELIX | VTSMX | VELIX / VTSMX | |
Total Expense Ratio | 1.03 | 0.14 | 736% |
Annual Report Gross Expense Ratio | 1.03 | 0.14 | 736% |
Fund Existence | 5 years | 33 years | - |
Gain YTD | 4.871 | 6.421 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 69.7M | 1.82T | 0% |
Annual Yield % from dividends | 0.27 | 1.12 | 24% |
Returns for 1 year | 3.66 | 13.89 | 26% |
Returns for 3 years | 27.79 | 62.08 | 45% |
Returns for 5 years | N/A | 95.59 | - |
Returns for 10 years | N/A | 198.05 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PCSGX | 14.71 | 0.16 | +1.10% |
PACE Small/Medium Co Growth Equity P | |||
ANOIX | 22.33 | 0.22 | +1.00% |
American Century Small Cap Growth Inv | |||
FIJYX | 29.63 | 0.13 | +0.44% |
Fidelity Advisor Biotechnology Z | |||
FAOIX | 38.46 | 0.14 | +0.37% |
Fidelity Advisor Overseas I | |||
WILCX | 10.42 | 0.03 | +0.29% |
Wasatch Global Value Institutional |